Skip to content
Clinical Trials – home

Turner's syndrome Life with Disease

3 / 6 trials open to patients17 countries1 support organisation

In short

Turner syndrome is a genetic condition affecting females that occurs when one X chromosome is missing or partially absent, leading to a range of health challenges that vary widely from person to person. With proper medical care, ongoing monitoring, and appropriate treatments, individuals with this condition can lead fulfilling, productive lives.

Key points

  • Turner syndrome affects approximately 1 in 2,000 to 2,500 live-born girls, but occurs in far more pregnancies that don't survive to term—highlighting that the condition is more common before birth than after[1].
  • With appropriate medical care including growth hormone therapy and estrogen replacement, individuals with Turner syndrome can lead normal, healthy, productive lives with good quality of life[11].
  • Heart defects occur in 30 to 50 percent of people with Turner syndrome, making cardiovascular monitoring one of the most critical aspects of lifelong care[4].
  • The two universal features of Turner syndrome are short stature (averaging 143 cm or 4'8" without treatment) and ovarian insufficiency leading to infertility in most cases[1].
  • Turner syndrome is not inherited—it happens completely by chance through a random chromosomal error, and advanced parental age does not increase the risk[3].
  • Diagnosis can occur at any stage of life—before birth through prenatal testing, at birth due to physical features, during childhood when growth problems become apparent, or even in adulthood during infertility investigations[2].
  • Regular monitoring for complications including high blood pressure, bone density loss, thyroid problems, hearing loss, and metabolic issues is essential throughout life for preventing serious health problems[11].
  • While most women with Turner syndrome cannot conceive naturally, advances in reproductive medicine including egg donation and IVF have made motherhood possible for some—though pregnancy carries increased cardiovascular risks that require careful evaluation[15].

Understanding the Outlook for Turner Syndrome

When a girl or woman receives a diagnosis of Turner syndrome, understanding what the future holds becomes an important concern for both patients and their families. The outlook for individuals with this condition has improved significantly over recent decades thanks to advances in medical care and a better understanding of how to manage associated health issues.

Turner syndrome can slightly reduce life expectancy compared to the general population, but the vast majority of people with the condition should be able to live relatively normal, healthy lives. The key to achieving the best possible outcome lies in receiving regular health checks and early treatment for any health problems that arise. This means working closely with a team of healthcare professionals who understand the condition and can monitor for complications before they become serious.

The prognosis varies considerably depending on several factors. The type of chromosomal abnormality matters—whether the X chromosome is completely missing (monosomy X) or only partially missing (mosaic Turner syndrome). Those with mosaic Turner syndrome often experience milder symptoms and may have a better overall outlook. Additionally, the presence and severity of heart defects significantly impact long-term health outcomes, as cardiovascular complications are among the most serious concerns for individuals with Turner syndrome.

It's important to understand that statistical information about life expectancy represents averages across many individuals. Each person's experience with Turner syndrome is unique, and many factors influence individual outcomes, including access to quality healthcare, early diagnosis, appropriate treatment, and management of associated conditions. With comprehensive medical care that includes regular monitoring of blood pressure, bone density, thyroid function, and cardiovascular health, many women with Turner syndrome enjoy active, fulfilling lives well into adulthood.

How Turner Syndrome Progresses Without Treatment

Understanding the natural course of Turner syndrome—how it develops when medical interventions are not provided—helps illustrate why early diagnosis and treatment are so important. Without appropriate medical care, individuals with this condition face several predictable patterns of development that differ significantly from typical female development.

The most noticeable feature that emerges without treatment is short stature. Girls with Turner syndrome grow more slowly than their peers, typically becoming noticeable around age five. Without growth hormone therapy, they experience a lack of the normal growth spurts that occur during childhood and adolescence. The average final adult height without treatment is approximately 143 centimeters (4 feet 8 inches), significantly shorter than the typical female adult height.

Puberty presents another major area where natural progression differs markedly from typical development. The ovaries in girls with Turner syndrome typically develop normally at first, but the egg cells usually die prematurely, and most ovarian tissue breaks down before birth. This means that without hormone replacement therapy, most girls with Turner syndrome will not undergo puberty naturally. They will not develop breasts, will not begin menstruating, and will experience primary amenorrhea—the absence of menstrual periods. Only a small percentage retain normal ovarian function through young adulthood, and even in these cases, function is typically limited.

Beyond growth and sexual development, untreated Turner syndrome leads to various other health consequences. The absence of naturally produced estrogen affects bone health, increasing the risk of developing osteoporosis at a younger age than would typically occur. Without estrogen, bones become thinner and more fragile, making fractures more likely. Cardiovascular problems that are present from birth may worsen over time without proper monitoring and intervention. Blood pressure problems can develop or worsen, particularly in individuals with certain heart defects.

Metabolic changes also occur as part of the natural progression. Without appropriate hormone treatment, individuals may develop an increased risk of obesity, diabetes, and an unhealthy lipid profile—a combination of factors that further increases cardiovascular risk. The thyroid gland may also develop problems, as Turner syndrome is associated with an increased likelihood of hypothyroidism, a condition where the thyroid doesn't produce enough hormone.

Possible Complications That May Arise

Turner syndrome is associated with a wide range of potential complications affecting multiple body systems. While not every individual will experience all of these complications, understanding what might occur helps with early detection and prompt treatment.

Cardiovascular complications represent some of the most serious concerns. Congenital heart defects occur in approximately 30 to 50 percent of individuals with Turner syndrome. The most common defects include coarctation of the aorta, where the major blood vessel leaving the heart becomes narrowed, and bicuspid aortic valve, where the valve connecting the heart to the aorta has only two leaflets instead of the normal three. These structural abnormalities can lead to several dangerous complications, including high blood pressure, heart failure, and most seriously, aortic dissection or rupture—a life-threatening emergency where the wall of the aorta tears.

Progressive aortic root dilatation, where the aorta gradually enlarges at its connection to the heart, can occur even in individuals who had normal heart examinations at birth. This risk is particularly elevated in those with a bicuspid aortic valve, coarctation, or untreated high blood pressure. Because of these risks, individuals with Turner syndrome require regular cardiac monitoring throughout their lives, even if initial cardiovascular examinations were normal.

Kidney and urinary tract abnormalities affect a significant proportion of individuals with Turner syndrome. These can include structural malformations such as horseshoe kidney, where the two kidneys are fused together, or problems with how the kidneys collect and drain urine. While many kidney abnormalities don't cause symptoms, some can lead to recurrent urinary tract infections or, in more severe cases, affect kidney function over time.

Hearing problems become increasingly common with age in Turner syndrome. Recurrent middle ear infections during childhood can lead to decreased hearing. Additionally, progressive sensorineural hearing loss—where the inner ear or nerve pathways to the brain are damaged—often develops. This type of hearing loss typically worsens gradually over time and requires monitoring and potential intervention with hearing aids.

Bone health complications include not only osteoporosis from lack of estrogen but also an increased risk of fractures and altered bone development. Some individuals experience unusual bone formation patterns, such as cubitus valgus (where the arms angle outward at the elbows) or problems with bone development in the hands and wrists. Skeletal abnormalities, while often not causing functional problems, may require monitoring.

Metabolic and endocrine complications extend beyond ovarian insufficiency. Many individuals with Turner syndrome develop thyroid problems, most commonly hypothyroidism, requiring lifelong thyroid hormone replacement. The risk of developing type 2 diabetes is elevated, particularly with increasing age. Many individuals also develop an atherogenic lipid profile—unfavorable cholesterol and triglyceride levels that increase the risk of cardiovascular disease.

Autoimmune conditions occur more frequently in Turner syndrome than in the general population. Beyond autoimmune thyroid disease, some individuals develop celiac disease (an immune reaction to gluten) or inflammatory bowel disease. Regular screening for these conditions helps ensure early detection and treatment.

Vision problems include an increased risk of strabismus (crossed or misaligned eyes), drooping eyelids, and other eye abnormalities. Some individuals are also at higher risk for developing high pressure within the eye, which can lead to glaucoma if not treated.

Impact on Daily Life and Activities

Living with Turner syndrome affects various aspects of daily life, though the degree of impact varies considerably from person to person. Understanding these effects helps individuals and families plan appropriate support and develop strategies for managing challenges.

Physical activities and sports participation require some consideration, particularly for those with cardiovascular abnormalities. Individuals with significant heart defects, aortic dilation, or uncontrolled high blood pressure may need to avoid certain high-intensity activities or contact sports that could potentially trigger cardiovascular complications. However, many people with Turner syndrome can participate safely in a wide range of physical activities with appropriate medical guidance. Regular exercise remains important for maintaining bone health, cardiovascular fitness, and overall wellbeing.

Short stature, while not a health problem in itself, can create practical challenges in daily life. Everyday tasks that others take for granted—reaching items on high shelves, using standard-height counters or equipment, driving a car with standard pedal positioning—may require adaptations or assistive devices. These physical adaptations are usually straightforward to implement, but they represent an ongoing aspect of managing life with the condition.

Learning and cognitive function in Turner syndrome typically involve specific patterns rather than overall intellectual disability. Most individuals have normal intelligence and normal language and reading skills. However, some people experience challenges with certain types of learning, particularly involving spatial awareness, mathematics, and nonverbal skills. These learning differences can affect performance in school subjects like geometry or subjects requiring strong visual-spatial processing. Some individuals also experience difficulties with attention, organization, or executive function skills—the mental processes that help with planning, focusing attention, and managing multiple tasks.

Social and emotional aspects of living with Turner syndrome can be challenging, particularly during adolescence and young adulthood. The visible differences in height and delayed puberty can affect self-esteem and social interactions during teenage years when fitting in with peers feels especially important. Not developing at the same time as friends can lead to feelings of being different or left behind. Some individuals experience social anxiety or have difficulty reading social cues, which may relate to the nonverbal learning challenges associated with Turner syndrome.

Coming to terms with infertility represents a significant emotional challenge for many women with Turner syndrome. While assisted reproductive technology has made biological motherhood possible for some through egg donation and in vitro fertilization, the inability to conceive naturally can be a source of grief and loss. This reality often becomes more emotionally significant during young adulthood when peers are starting families.

Managing the medical aspects of Turner syndrome requires ongoing attention and coordination. Regular medical appointments for monitoring various health parameters—cardiovascular checks, bone density scans, hearing tests, blood tests for thyroid and metabolic function—become a routine part of life. Taking daily medications, particularly hormone therapies, requires consistency and attention. This level of medical management can sometimes feel burdensome, particularly for adolescents and young adults seeking independence.

Employment and career development are generally not significantly limited by Turner syndrome for most individuals. People with the condition work successfully in a wide range of fields and professions. However, those who experience learning difficulties may benefit from additional educational support or career guidance to find roles that match their strengths. Physical limitations from short stature rarely restrict career options but may require workplace accommodations in some situations.

Despite these challenges, many coping strategies and supports can help individuals thrive. Early intervention for learning differences through specialized educational support can help children develop strategies to work around their challenges. Counseling or therapy can provide valuable support for managing the emotional and social aspects of the condition, particularly during adolescence. Support groups connecting individuals with Turner syndrome allow them to share experiences and strategies with others who understand their situation. Focusing on individual strengths and abilities, rather than limitations, helps build confidence and resilience.

Supporting Families Through Clinical Research

For families affected by Turner syndrome, understanding clinical trials and research studies becomes an important consideration. These studies play a crucial role in advancing knowledge about the condition and developing improved treatments, but navigating the world of clinical research can feel overwhelming without proper guidance.

Clinical trials for Turner syndrome typically focus on several key areas. Research may investigate new approaches to growth hormone therapy to optimize height outcomes, study different estrogen replacement strategies to better mimic natural puberty and protect bone health, or explore treatments that might help preserve ovarian function. Some studies examine ways to prevent or manage specific complications, such as cardiovascular problems or metabolic issues. Others investigate the cognitive and psychological aspects of Turner syndrome to develop better support strategies.

Families considering clinical trial participation should understand what these studies involve. Clinical trials are research studies designed to answer specific questions about medical treatments, procedures, or diagnostic approaches. They follow strict protocols to ensure participant safety and collect reliable information. Trials typically have specific eligibility criteria, meaning not every individual with Turner syndrome will qualify for every study. Criteria might include specific age ranges, particular symptoms or complications, previous treatments received, or other health factors.

The benefits of participating in clinical research extend beyond potential individual advantages. Participants often receive very close medical monitoring and access to cutting-edge treatments before they become widely available. They contribute to advancing scientific knowledge that will help future generations affected by Turner syndrome. Many families find meaning and purpose in contributing to research that may eventually improve care for others facing similar challenges.

However, clinical trial participation also involves considerations and potential downsides. Trials may require additional time commitments for extra visits, testing, or procedures beyond standard care. There may be uncertainty about whether a particular treatment will prove beneficial, particularly in studies comparing new treatments to standard approaches. Some trials involve placebos—inactive treatments—though studies addressing serious aspects of Turner syndrome typically ensure all participants receive at least standard care. Families need to weigh these factors carefully based on their individual circumstances.

Finding appropriate clinical trials requires knowing where to look. Healthcare providers specializing in Turner syndrome often know about relevant studies and can make referrals. Online registries maintain searchable databases of clinical trials, allowing families to search for studies related to Turner syndrome in their geographic area or that accept participants remotely. Patient advocacy organizations focused on Turner syndrome often maintain information about ongoing research and can help connect families with appropriate studies.

Relatives can provide crucial support for patients considering or participating in clinical trials. Families can help by researching potential studies and discussing options together. Understanding the details of a study—what it involves, potential risks and benefits, time commitments required—allows for informed decision-making. Accompanying the patient to study visits provides both practical and emotional support. Helping maintain any records or complete any at-home requirements of the study assists with successful participation. Perhaps most importantly, respecting the individual's decision about whether to participate, while providing guidance and support, empowers patients to take an active role in their healthcare decisions.

When evaluating a clinical trial, certain questions can help families make informed decisions. What is the purpose of the study? What exactly will participation involve in terms of visits, tests, and treatments? What are the potential risks and discomforts? What are the possible benefits, both to the participant and to future patients? How long will participation last? What happens after the study ends? Will the participant be able to continue receiving the treatment if it proves beneficial? Is there any cost associated with participation, or will the study cover related expenses? Asking these questions helps families understand what they're agreeing to and make choices aligned with their values and circumstances.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Growth hormone (Human growth hormone) – Used in childhood to promote growth and prevent short stature in adulthood; treatment typically continues until the patient reaches a bone age of 14 years
  • Estrogen (Estrogen replacement therapy) – Initiated during preteen or teenage years (typically age 12-15) to support pubertal development, promote breast development, maintain bone health, and support reproductive organ function
  • Progestin – Added to estrogen therapy after 6-18 months to complete hormone replacement for menstrual cycle regulation
  • Thyroid replacement hormones – Used to treat hypothyroidism (underactive thyroid), which commonly develops in individuals with Turner syndrome
  • Calcium and Vitamin D supplements – Recommended starting at age 10 to support bone health and prevent osteoporosis
  • Antihypertensive agents – Used to manage high blood pressure, which is common in individuals with Turner syndrome, particularly those with heart defects

Did you know?

  1. Turner syndrome is responsible for approximately 10 percent of all first-trimester miscarriages, and it's estimated that 99 percent of pregnancies with a complete monosomy X chromosomal pattern do not survive to term[2].
  2. The condition was first fully described by German pediatrician Otto Ullrich in 1930, eight years before Henri Turner's independent description in 1938, which is why it's sometimes called Ullrich-Turner syndrome[3].
  3. Although Turner syndrome is a chromosomal condition, advanced parental age is not considered a significant risk factor—unlike Down syndrome—and it occurs completely by chance with no clearly established environmental causes[3].

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Turner's syndrome

Recruiting trials first

See all 6 trials →
Quick filters

6 clinical trials in this condition

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:Estradiol
  • Sponsor:Region Midtjylland
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:CARBOMER 980
  • Sponsor:Region Midtjylland
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Vosoritide
  • Sponsor:Biomarin Pharmaceutical Inc.
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Somapacitan
  • Sponsor:Novo Nordisk A/S
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Substances:Somapacitan
  • Sponsor:Novo Nordisk A/S
See all 6 trials →filters applied: condition = Turner's syndrome

Where to find support

Patient organisations offering help, community and advocacy

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).